Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017
- PMID: 35775106
- PMCID: PMC9530581
- DOI: 10.1111/irv.13003
Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017
Abstract
Background: Respiratory syncytial virus (RSV) and influenza are important causes of disease in children and adults. In Australia, information on the burden of RSV in adults is particularly limited.
Methods: We used time series analysis to estimate respiratory, acute respiratory infection, pneumonia and influenza, and bronchiolitis hospitalisations attributable to RSV and influenza in Australia during 2009 through 2017. RSV and influenza-coded hospitalisations in <5-year-olds were used as proxies for relative weekly viral activity.
Results: From 2009 to 2017, the estimated all-age average annual rates of respiratory hospitalisations attributable to RSV and seasonal influenza (excluding 2009) were 54.8 (95% confidence interval [CI]: 20.1, 88.8) and 87.8 (95% CI: 74.5, 97.7) per 100,000, respectively. The highest estimated average annual RSV-attributable respiratory hospitalisation rate per 100,000 was 464.2 (95% CI: 285.9, 641.2) in <5-year-olds. For seasonal influenza, it was 521.6 (95% CI: 420.9, 600.0) in persons aged ≥75 years. In ≥75-year-olds, modelled estimates were approximately eight and two times the coded estimates for RSV and seasonal influenza, respectively.
Conclusions: RSV and influenza are major causes of hospitalisation in young children and older adults in Australia, with morbidity underestimated by hospital diagnosis codes.
Keywords: RSV hospitalisation; burden; epidemiology; influenza hospitalisation; regression modelling; time series analysis.
© 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
Hannah Moore is a lead investigator on a Merck Sharp and Dohme Investigator Initiated study and has previously received consultancy payment for participation in expert input forums. These activities are not related to her involvement in this current manuscript. David Muscatello is an unpaid member of the Immunisation Coalition, a not‐for‐profit organisation that delivers science‐based advocacy for immunisation against infectious disease in Australia. The Coalition's revenue sources include healthcare and pharmaceutical companies. All other authors reported no known potential conflicts of interest.
Figures


References
-
- Shi T, Denouel A, Tietjen AK, et al. Global disease burden estimates of respiratory syncytial virus‐associated acute respiratory infection in older adults in 2015: a systematic review and meta‐analysis. J Infect Dis. 2019;222(Supplement_7):S577‐S583. - PubMed
-
- Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946‐958. doi:10.1016/S0140-6736(17)30938-8 - DOI - PMC - PubMed
-
- World Health Organization . Global influenza strategy 2019–2030. https://apps.who.int/iris/handle/10665/311184. Accessed July 9, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical